M&A

LifeScience Weekly Digest: Key Industry Updates (6th – 10th January) 

by

In early 2025, significant developments across the biopharmaceutical and medical device sectors shaped the healthcare landscape. Stryker’s $4.9 billion acquisition of Inari Medical, Transcarent’s $621 million deal for Accolade, and several FDA designations for investigational treatments, such as Johnson & Johnson’s nipocalimab, highlight industry advancements. Medicare’s rescinding of coverage for certain cancer genetic tests and … Read more

Transcarent paying $621M to acquire health benefits navigator Accolade 

by

Transcarent has announced plans to acquire Accolade for $621 million, marking a significant step toward its mission of delivering affordable and high-quality healthcare solutions. The acquisition will combine Transcarent’s innovative WayFinding and care solutions with Accolade’s personalized healthcare platform, creating a unified and comprehensive healthcare experience for users.  This collaboration aims to enhance accessibility to … Read more

Organon Expands Dermatology Portfolio with Acquisition of Dermavant and Its VTAMA Cream

by

Organon, a global healthcare company dedicated to improving the health of women throughout their lives, has announced the acquisition of Dermavant Sciences Ltd., a dermatology-focused subsidiary of Roivant Sciences. This acquisition will broaden Organon’s dermatology capabilities in the U.S. and beyond. The move aligns with Organon’s long-term strategy of expanding into therapeutic areas with high … Read more

EQT to Acquire GeBBS Healthcare Solutions

by

EQT Private Capital Asia has announced its agreement to acquire a controlling interest in GeBBS Healthcare Solutions from ChrysCapital. GeBBS specializes in revenue cycle management, health information management (HIM), and medical billing services, helping U.S.-based healthcare providers improve their financial performance through optimized revenue cycle processes and accurate coding and billing practices. Founded in 2005, … Read more